HK
Hikma Pharmaceuticals PLC
HKMPY · OTC
$41.31 +0.00% (+$0.00)
1M -7.38%
Market Cap $4.32B
P/E Ratio 10.71x
Div. Yield 4.16%
ROE 16.18%
Bulios Fair Price
$42.71
3.4% upside
Trenutna cena
$41.31
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price se delnica HKMPY trenutno trguje blizu svoje poštene vrednosti. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
6/9Valuation
86 /100
Cheap P/FCF 26.58x
P/S 1.29x
P/B 1.66x
Growth
60 /100
Stable Rev. growth 10.07%
FCF growth 18.95%
Book val. growth 6.69%
Profitability
65 /100
Moderate Net margin 12.00%
Op. margin 18.63%
FCF margin 4.84%
Quality
65 /100
Average ROE 16.18%
ROA 7.11%
Asset turnover 0.59x
Debt
74 /100
Low Current ratio 1.82x
Int. coverage 5.89x
Net debt/EBITDA 1.58x
Stability
83 /100
Stable Rev. volatility 3.63%
EPS volatility 46.35%
Profitable years 6
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o HKMPY
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Said Samih Taleb Darwazah
Employees
9,400
Headquarters
London